Fingerprint
Dive into the research topics of 'A novel doxorubicin prodrug with controllable photolysis activation for cancer chemotherapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A novel doxorubicin prodrug with controllable photolysis activation for cancer chemotherapy
Stuart Ibsen, Eran Zahavy, Wolf Wrasdilo, Michael Berns, Michael Chan, Sadik Esener
Research output: Contribution to journal › Article › peer-review
88
Scopus
citations